Successful Treatment of
bacteriophage
phage therapy
prosthetic joint
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
21 06 2021
21 06 2021
Historique:
received:
20
05
2021
revised:
12
06
2021
accepted:
14
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
19
1
2022
Statut:
epublish
Résumé
Successful joint replacement is a life-enhancing procedure with significant growth in the past decade. Prosthetic joint infection occurs rarely; it is a biofilm-based infection that is poorly responsive to antibiotic alone. Recent interest in bacteriophage therapy has made it possible to treat some biofilm-based infections, as well as those caused by multidrug-resistant pathogens, successfully when conventional antibiotic therapy has failed. Here, we describe the case of a 61-year-old woman who was successfully treated after a second cycle of bacteriophage therapy administered at the time of a two-stage exchange procedure for a persistent methicillin-sensitive
Identifiants
pubmed: 34205687
pii: v13061182
doi: 10.3390/v13061182
pmc: PMC8233819
pii:
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : T32 AI007036
Pays : United States
Références
J Heart Lung Transplant. 2019 Apr;38(4):475-476
pubmed: 30661974
Infect Control Hosp Epidemiol. 2018 Oct;39(10):1189-1195
pubmed: 30157981
Open Forum Infect Dis. 2018 Oct 24;5(11):ofy269
pubmed: 30474047
Am J Rhinol Allergy. 2014 Jan-Feb;28(1):3-11
pubmed: 24717868
J Arthroplasty. 2021 May;36(5):1484-1489.e3
pubmed: 33422392
PLoS One. 2017 Jul 25;12(7):e0181671
pubmed: 28742812
Clin Microbiol Rev. 2014 Apr;27(2):302-45
pubmed: 24696437
FEMS Microbiol Lett. 2004 Mar 12;232(1):1-6
pubmed: 15061140
Bacteriophage. 2012 Jul 1;2(3):159-167
pubmed: 23275867
Bacteriophage. 2016 Aug 11;6(3):e1220348
pubmed: 27738558
FEMS Microbiol Lett. 2016 Feb;363(3):
pubmed: 26738755
J Clin Med. 2021 Feb 25;10(5):
pubmed: 33668957
APMIS. 2007 Aug;115(8):891-9
pubmed: 17696944
Front Med (Lausanne). 2021 May 05;8:569159
pubmed: 34026768
J Immunol. 2018 May 1;200(9):3037-3044
pubmed: 29685950
Open Forum Infect Dis. 2020 Aug 27;7(9):ofaa389
pubmed: 33005701
Pharmaceuticals (Basel). 2021 Mar 08;14(3):
pubmed: 33800146
World J Gastrointest Pharmacol Ther. 2017 Aug 6;8(3):162-173
pubmed: 28828194
Infection. 2019 Aug;47(4):665-668
pubmed: 31102236
Front Microbiol. 2020 Mar 04;11:327
pubmed: 32194532
Virologie (Montrouge). 2018 Feb 1;24(1):49-56
pubmed: 32108017
Viral Immunol. 2014 Aug;27(6):295-304
pubmed: 24893003
mBio. 2021 Feb 23;12(1):
pubmed: 33622728
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28807909
Int J Gen Med. 2018 Jan 18;11:25-32
pubmed: 29403304
Bacteriophage. 2016 Aug 5;6(3):e1219440
pubmed: 27738555
Future Microbiol. 2014;9(8):987-1007
pubmed: 25302955
Clin Infect Dis. 2021 Jul 1;73(1):e144-e151
pubmed: 32699879
Am J Infect Control. 2008 Dec;36(10):S175.e9-11
pubmed: 19084156
Curr Opin Microbiol. 2017 Oct;39:48-56
pubmed: 28964986
Front Immunol. 2019 Nov 14;10:2607
pubmed: 31803179